window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics

    AmacaThera named Life Sciences Ontario emerging company of the year

    AmacaThera has been named Emerging Company of the Year by [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery

    Syngene International has entered a collaboration with Johns Hopkins University [...]

    May 5, 2026
  • Drug Discovery & Development

    QDX opens Gordon Bell-winning EXESS quantum chemistry engine to academic researchers

    QDX has opened external access to EXESS, its GPU-accelerated quantum [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close

    IgniteData has appointed Laura Hilty as chief strategy officer and [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research

    SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine

    BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    5 Insights on Data Foundations From Top Pharma Leaders

    As the pharmaceutical industry moves from AI experimentation to execution, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Evinova and Bristol Myers Squibb collaborate on AI-driven clinical trial optimisation

    Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

    May 5, 2026
  • Drug Discovery & Development,Therapeutic Areas

    Circio and University of Texas Medical Branch partner on infectious disease research using circular RNA

    Circio has entered a research collaboration with the University of [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain

    ACG Packaging Materials joins World Economic Forum Global Lighthouse Network as first pharma packaging company

    ACG Packaging Materials has joined the World Economic Forum’s Global [...]

    May 5, 2026
Previous101112Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top